Callum P Mutch
@callumpmutch.bsky.social
1.2K followers 530 following 48 posts
Microbiologist and Infectious Disease physician. Educator and podcaster: @idiots-pod.bsky.social Interests: Sim&Mastery, Digital healthcare, cycling, TTRPGs. He/him
Posts Media Videos Starter Packs
Reposted by Callum P Mutch
callumpmutch.bsky.social
Edinburgh is such a great place to live and work. Particularly in this sunny may.

Want to work here too (as a med micro +/- ID consultant)?

Well, check out this job advert: apply.jobs.scot.nhs.uk/Job/JobDetai...
Consultant in Medical Microbiology :Various sites
apply.jobs.scot.nhs.uk
Reposted by Callum P Mutch
jakescottmd.bsky.social
< 72 h from launch → 48 placebo / active-controlled vaccine RCTs logged - now including all 5 COVID trials

1.43 M participants

Crowd-powered, freely accessible evidence that buries the “never placebo-tested” myth.

Browse or drop a PMID 👇
bit.ly/3EuYzqI

cc @bradspellberg.bsky.social
callumpmutch.bsky.social
Penicillin Susceptible Staphylococcus aureus IS REAL!
callumpmutch.bsky.social
"this is all just part of my CPD record"

Seems like a good catchphrase
Reposted by Callum P Mutch
angelahuttner.bsky.social
Now it’s @drneilstone.bsky.social talking about social media and medicine. “Bluesky is the dominant platform now.”
He said it. We will get him over to Bluesky for good! 💪🏼😉😁
#ESCMIDGlobal
#IDSky #MedSky
Dr Neil Stone talking about social media & medicine in Vienna at ESCMID Global.
Reposted by Callum P Mutch
amh10.bsky.social
Why is this not happening #ESCMID2025
callumpmutch.bsky.social
Was looking for this content and couldn't find it. I'm newly covering maxfax and ENT areas - couldn't see that much content. Any recommendations on conferences for these?
callumpmutch.bsky.social
An example of a commercially available system below.

Strikes me that locally we have all this data but due to different systems there is no way to view as overview and so need to spend time creating summaries.

Consequence of digitised systems rather than digital transformation of care?
callumpmutch.bsky.social
Challenge of clinical decision support systems is the lag of legislation from technological change. Overarching challenge in many areas #escmidglobal
callumpmutch.bsky.social
There was more covered. Great session!
callumpmutch.bsky.social
5. Update on enterococcal breakpoints. Including other species

Remember intrinsic vanc resistance ones! Cassesiflavus and gallinarum
callumpmutch.bsky.social
Update on upcoming new anaerobic breakpoints - exciting but methodology difficult and so likely ref lab still
callumpmutch.bsky.social
4. Answers to questions about dosing: Generally to use breakpoints table. But in IE breakpoints refer to ESC guidelines. Also rationale for no I category and assumption that highest dose always used

This seems less useful (to me) given issues in ESC dosing tables and clinical data on oral switch.
callumpmutch.bsky.social
3. Breakpoints for cefepime-enmetazobactam (always a pleasure to try to spell) and aztreonam-avibactam
callumpmutch.bsky.social
2. Stenotrophomonas updated breakpoints:
Updates CoT R breakpoint. ECOFFS for other agents. And a nice bonus on mechanisms of beta lactams resistance
callumpmutch.bsky.social
EUCAST updates #ESCMIDglobal

1. Strep pneumonia updated algorithm:

Use oxacillin disk, if >20mm then report A to all beta lactams. If <20mm read benpen 1 unit disk. Great presentation showing data behind and how well differentiates S/I/R
callumpmutch.bsky.social
I'm now not so sure about HECK Yes. Patrick Harris was suggesting we should be more reluctant to switch from piptaz etc to mero based on risk of ampC unless Enterobacter.

Will be interesting to see next ESCMID DTR GN guidelines and IDSA 2025 on AmpC.

But for purposes of teaching, yes - HECK yes!
callumpmutch.bsky.social
Interesting chart. Some doubt about oral beta lactams for bacteraemia oral switch given time/MIC concerns and not meeting PD target in Enterobacterales with higher MICs. Was this addressed at all? Perhaps need an organism/MIC specific approach?
Reposted by Callum P Mutch
amh10.bsky.social
This is a sensible bar for IVOS #ESCMID2025
callumpmutch.bsky.social
It is so complex but Patrick Harris's talk key - clinical data (so far) shows mostly need to worry about Enterobacter CC. So I will watch with interest but likely not teach on till we have more clinical!
callumpmutch.bsky.social
We talk about inducible AmpC and derepression of AmpC inducible, but what are the mechanisms?

Well, it's complex, but depends on the species. AmpR and PBP4 key players. I might need to watch this talk again.... (and easily can because the conference platform is excellent)! #escmidglobal
callumpmutch.bsky.social
Useful summary of inducible AmpC - strength of inducement and susceptibility to hydrolysis #escmidglobal
callumpmutch.bsky.social
Just gotten my head round the public transport and #escmidglobal is almost done! Having pre-paid travel has made it very easy!